Over the last decade, the life sciences industry has used digital advertising at an increasing rate to engage with patients throughout the drug development life cycle. From creating disease state awareness, to driving drug adherence, the trend particularly accelerated during 2020 and 2021, as pharmaceutical brands looked for ways to stay engaged with their patients…

Although biologics and biosimilar drugs only represent 2% of U.S. prescription volume, these naturally sourced medications have recently become the focus of much discussion across healthcare channels. Biologics – often considered specialty drugs – have accounted for as much as 37% of drug spending in a single year.

While only half as many are diagnosed, researchers estimate that hypothyroidism affects as much as 10% of the general population. Also known as “underactive thyroid,” this condition is characterized by a thyroid gland that doesn’t produce enough thyroid hormone (TH).

To create a market assessment, more and more brand strategists are moving towards the use of RWD and RWE. In this blog, we walk through a hypothetical example – sizing the market for Hemophilia A – doing just that.  Creating a market assessment is a critical step in commercializing a new drug. This is because…

Developing, testing and getting approval for a new drug is a tough feat – but only half the battle. Now that your new drug is ready to be commercialized, you have to get it to the right patients, which starts with finding the right physicians. Here’s how this process works – and how to use…

On December 1st each year the world unites to commemorate World AIDS Day to support those living with HIV and honor the memory of those who died from AIDS-related illnesses. This year’s theme is “Equalize” to inform people globally of inequalities as one of the growing challenges. Enormous progress has been made in the treatment,…

Today, the number of Americans aged 65 and older living with Alzheimer’s dementia is estimated at 6.2 million. Without medical breakthroughs to slow or cure the disease, it is projected to approach 13.8 million by 2060. Alzheimer’s is the fifth-leading cause of death among Americans aged 65 and older and in the past twenty years,…

Today, more than 130 million adults in the United States are dealing with the health consequences of living with prediabetes and diabetes.

Ovarian cancer accounts for more deaths than any other cancer of the female reproductive system. This illness often begins with little or no symptoms, meaning patients and their doctors discover it when it’s too late for preventative treatment. Conducting successful ovarian cancer clinical trials can help us uncover new treatments and save lives — but…